KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (KALV)

CUSIP: 483497103

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+6,300,329
Put/Call ratio
14%
SEC-reported price per share
$16.15
Number of holders
162
Value change
+$110,817,109
Number of buys
86
Open additional details 1 more signal available
Number of sells
67
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
54,311,522

Security key

483497103

Report period

Q4 2025

Institutions

162

Top holders

10

Ownership snapshot

Top reported holders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
TANG CAPITAL MANAGEMENT LLC
Disclosed value leader
Venrock Adviser, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G 13F Lead comparable stake: 9.9% 13D/G row: TANG CAPITAL MANAGEMENT LLC Showing 1-6 of 15 holder rows.

Quick read

TANG CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TANG CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership Top 5
TANG CAPITAL MANAGEMENT LLC 9.9%
Capital World Investors 6.4%
Vestal Point Capital, LP 1.5%
Venrock Adviser, LLC 12%
Frazier Life Sciences Management,... 9.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
TANG CAPITAL MANAGEMENT LLC
13D/G 13F
Company
9.9%
$63,650,358
4,941,798 shares
$0 31 Mar 2025
Capital World Investors
13D/G 13F
Company
6.4%
$40,927,321
3,177,587 shares
$0 31 Mar 2025
Vestal Point Capital, LP
13D/G 13F
Company
1.5%
$9,135,000
750,000 shares
$0 30 Sep 2025
Venrock Adviser, LLC
13F
Company
13F
12%
$81,959,037
6,728,985 shares
30 Sep 2025
Frazier Life Sciences Management, L.P.
13F
Company
13F
9.3%
$61,385,580
5,039,867 shares
30 Sep 2025
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
13F
8.8%
$58,082,912
4,768,712 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
162
Shares
66,955,522
Rows available
162
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
143
Q4 2025 holders
162
Holder diff
19
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .